Scientists propose CDK2 enzyme as new target for cancer therapy
An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...
The EMBO Journal23h
LATS1/2 inactivation in the mammary epithelium drives the evolution of a tumor-associated niche
LATS1/2-inactivation and consequent nuclear YAP/TAZ hyperactivation in the mammary epithelium drives the development of a pro ...
TMCnet3d
Oragenics, Inc. Announces Partnership with BRAINBox Solutions to Revolutionize Concussion Diagnosis and Treatment
With over 5 million concussions occurring annually in the U.S. alone, there is a significant unmet need for effective diagnostic and therapeutic solutions. This partnership positions Oragenics and ...
Tilray Expands Medical Cannabis Portfolio in Germany
Tilray THC50 CBD50 (25ml): A high-potency 1:1 medical cannabis extract designed for patients requiring higher cannabinoid content, offering an option for those who need stronger therapeutic effects ...
Observer6d
BEING ALL EARS: Equines have ability to communicate
Imagine if a horse could talk. Actually, they do! But you must know how to listen, watch and interpret! That is called ...